September 26, 2016 1:50 AM ET

Life Sciences Tools and Services

Company Overview of Ajinomoto Althea, Inc.

Company Overview

Ajinomoto Althea, Inc. provides biopharmaceutical contract development and manufacturing services to biotechnology and pharmaceutical companies worldwide. It offers development services in the areas of process development, protein formulation technology, analytical development and validation, and regulatory support. The company also provides services related to drug substances, such as cGMP protein/plasmid DNA production, microbial cell banking, patented protein expression technology, analytics, and regulatory support. In addition, it offers drug product manufacturing services, including formulation, aseptic vial filling, aseptic pre-filled syringe filling, lyophilization, stability and rele...

11040 Roselle Street

San Diego, CA 92121

United States

Founded in 1997





Key Executives for Ajinomoto Althea, Inc.

Chief Executive Officer and President
Age: 52
Co-Founder and Director
Age: 57
Chief Financial Officer and Senior Vice President
Age: 63
Senior Vice President of Operations
Vice President of Biologics
Compensation as of Fiscal Year 2016.

Ajinomoto Althea, Inc. Key Developments

Ajinomoto Althea, Inc. Expands its Capacity of Fill Finish Manufacturing with Addition of Second Shift

Ajinomoto Althea, Inc. announced it is expanding the capacity of its Fill and Finish operations through the addition of a second manufacturing shift. Althea's contract manufacturing business has experienced exceptionally strong growth driven by biotech companies outsourcing to Althea sterile fill and finish parenteral manufacturing to support their clinical and commercial drug programs. Althea's second shift will come on-line in early June, increasing the number of manufacturing slots for commercial and clinical drug programs, thereby significantly reducing lead times from project kickoff to fill date. To support this significant increase in its parenteral manufacturing capacity, Althea has invested in additional operational capabilities, more visual inspection suites, automated quality systems, and project management expansion.

Ajinomoto Althea, Inc. Expands Manufacturing Capabilities to Antibody Drug Conjugate Fill Finish and Bioconjugation

Ajinomoto Althea, Inc. announced it is expanding its existing biological drug product manufacturing operations to include highly active materials such as Antibody Drug Conjugates (ADCs). The new facility is located in close proximity to existing Althea operations in San Diego, CA.

Ajinomoto Althea, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015

Ajinomoto Althea, Inc. Presents at 7th annual Biotech Showcase Conference 2015, Jan-12-2015 . Venue: Parc 55 Wyndham San, Francisco - Union Square, San Francisco, CA 94102, United States.

Similar Private Companies By Industry

Company Name Region
10X Genomics, Inc. United States
4G Clinical, Inc. United States
AAPharmaSyn LLC United States
Abiant, Inc. United States
aBioBot, Inc. United States

Recent Private Companies Transactions

No transactions available in the past 12 months.

The information and data displayed in this profile are created and managed by Capital IQ, a Standard & Poor's company. does not create or control the content. For inquiries, please contact Capital IQ directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
NYC2012, Inc. United States
Bertelsmann AG Europe
Rush University United States
Bloomberg L.P. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact Ajinomoto Althea, Inc., please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at